United Capital Management Of Ks, Inc. Sorrento Therapeutics, Inc. Transaction History

United Capital Management Of Ks, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$1.51 - $2.88 $6,779 - $12,931	-4,490 Reduced 19.51%	18,525 $29,000
Q2 2022 Aug 04, 2022	SELL	$1.24 - $2.33 $7,905 - $14,853	-6,375 Reduced 21.69%	23,015 $46,000
Q1 2022 Apr 26, 2022	BUY	$2.0 - $4.9 $800 - $1,960	400 Added 1.38%	29,390 $68,000
Q4 2021 Jan 18, 2022	BUY	$4.65 - $7.23 $9,300 - $14,460	2,000 Added 7.41%	28,990 $135,000
Q3 2021 Oct 27, 2021	BUY	$7.41 - $10.99 $44,645 - $66,214	6,025 Added 28.74%	26,990 $206,000
Q2 2021 Jul 26, 2021	BUY	$6.35 - $10.0 $133,127 - $209,650	20,965 New	20,965 $203,000

5.51M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of United Capital Management Of Ks, Inc., based on Form 13F filings with the SEC.

Stay updated on United Capital Management Of Ks, Inc. with notifications on news.